Comparison of different prime-boost regimes with DNA and recombinant Orf virus based vaccines expressing glycoprotein D of pseudorabies virus in pigs

Vaccine

Volumn 28, Issue 7, 2010, Pages 1808-1813

  van Rooij, E M A ^a   Rijsewijk, F A M ^b   Moonen Leusen, H W ^a   Bianchi, A T J ^a   Rziha, H J ^c  

^a WAGENINGEN UNIVERSITY   (Netherlands)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c FEDERAL RESEARCH INSTITUTE FOR ANIMAL HEALTH   (Germany)

Author keywords

DNA vaccine; Orf virus based vaccine; Prime boost; Pseudorabies virus; Swine

Indexed keywords

DNA VACCINE; GLYCOPROTEIN D; LIVE VACCINE; PARAPOXVIRUS VACCINE; PSEUDORABIES VACCINE; SUVAXYN I; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; EXPERIMENTAL PIG; IMMUNOGENICITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PSEUDORABIES; PSEUDORABIES HERPETOVIRUS; VACCINATION;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; ANTIBODY FORMATION; CELL PROLIFERATION; HERPESVIRUS 1, SUID; IMMUNIZATION, SECONDARY; LYMPHOCYTE ACTIVATION; ORF VIRUS; PSEUDORABIES; SWINE; VACCINES, DNA; VIRAL ENVELOPE PROTEINS; VIRAL VACCINES;

EID: 75249083032     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.12.004     Document Type: Article

References (34)

1. Mettenleiter T.C. Aujeszky's disease (pseudorabies) virus: the virus and molecular pathogenesis-state of the art, June 1999. Vet Res 31 (2000) 99-115
2. Bouma A. Determination of the effectiveness of Pseudorabies marker vaccines in experiments and field trials. Biologicals 33 (2005) 241-245
3. Zinkernagel R. On natural and artificial vaccinations. Annu Rev Immunol 21 (2003) 515-546
4. Nielsen H.S., Oleksiewicz M.B., Forsberg R., Stadejek T., Botner A., and Storgaard T. Reversion of a live porcine reproductive and respiratory syndrome virus vaccine investigated by parallel mutations. J Gen Virol 82 (2001) 1263-1272
5. Vossen M.T., Westerhout E.M., Soderberg-Naucler C., and Wiertz E.J. Viral immune evasion: a masterpiece of evolution. Immunogenetics 54 (2002) 527-542
6. Koppers-Lalic D., Reits E.A., Ressing M.E., Lipinska A.D., Abele R., Koch J., et al. Varicelloviruses avoid T cell recognition by UL49.5-mediated inactivation of the transporter associated with antigen processing. Proc Natl Acad Sci USA 102 (2005) 5144-5149
7. Van Rooij E.M., Haagmans B.L., de Visser Y.E., de Bruin M.G., Boersma W., and Bianchi A.T. Effect of vaccination route and composition of DNA vaccine on the induction of protective immunity against pseudorabies infection in pigs. Vet Immunol Immunopathol 66 (1998) 113-126
8. Gerdts V., Jons A., Makoschey B., Visser N., and Mettenleiter T.C. Protection of pigs against Aujeszky's disease by DNA vaccination. J Gen Virol 78 (1997) 2139-2146
9. Dorner F., and Barrett P.N. Vaccine technology: looking to the future. Ann Med 31 (1999) 51-60
10. Rocha C.D., Caetano B.C., Machado A.V., and Bruna-Romero O. Recombinant viruses as tools to induce protective cellular immunity against infectious diseases. Int Microbiol 7 (2004) 83-94
11. Büttner M., and Rziha H.-J. Parapoxviruses: from the lesion to the viral genome. J Vet Med Ser B 49 (2002) 7-16
12. Fischer T., Planz O., Stitz L., and Rziha H.-J. Novel recombinant parapoxvirus vectors induce protective humoral and cellular immunity against lethal herpesvirus challenge infection in mice. J Virol 77 (2003) 9312-9323
13. Henkel M., Planz O., Fischer T., Stitz L., and Rziha H.-J. Prevention of virus persistence and protection against immunopathology after Borna disease virus infection of the brain by a novel Orf virus recombinant. J Virol 79 (2005) 314-325
14. Voigt H., Merant C., Wienhold D., Braun A., Hutet E., Le Potier M.F., et al. Efficient priming against classical swine fever with a safe glycoprotein E2 expressing Orf virus recombinant (ORFV VrV-E2). Vaccine 31 (2007) 5915-5926
15. Dory D., Fischer T., Béven V., Cariolet R., Rziha H.-J., and Jestin A. Prime-boost immunization using DNA vaccine and recombinant Orf virus protects pigs against Pseudorabies virus (Herpes suid 1). Vaccine 24 (2006) 6256-6263
16. Woodland D.L. Jump-starting the immune system:prime-boostng comes of age. Trends Immunol 25 (2004) 98-104
17. Haagmans B.L., Van Rooij E.M., Dubelaar M., Kimman T.G., Horzinek M.C., Schijns V.E., et al. Vaccination of pigs against pseudorabies virus with plasmid DNA encoding glycoprotein D. Vaccine 17 (1999) 1264-1271
18. MacFerran J.B., and Dow C. Studies on immunisation of pigs with the Bartha strain of Aujeszky's disease virus. Res Vet Sci 19 (1975) 17-22
19. Bartha A. Experimental reduction of virulence of Aujeszky's disease. Ungar Tier Monats 16 (1961) 42-45
20. Stellman C., Vannier P., Chappuis G., Brun A., Dauvergne M., Fargeaud D., et al. The potency testing of pseudorabies vaccines in pigs. A proposal for a quantitative criterion and a minimum requirement. J Biol Standard 17 (1989) 17-27
21. Bitsch V., and Eskildsen M. A comparative examination of swine sera for antibody to Aujeszky virus with the conventional and modified virus-serum neutralization test and a modified complement fixation test. Acta Vet Scand 17 (1976) 142-145
22. Kimman T.G., Brouwers R.A., Daus F.J., Van Oirschot J.T., and van Zaane D. Measurement of isotype-specific antibody responses to Aujeszky's disease virus in sera and mucosal secretions of pigs. Vet Immunol Immunopathol 31 (1992) 95-113
23. StatXact 4 for Windows (1998), Cytel Software Corporation, Cambridge, USA
24. Page G.R., Wang F.-I., and Hahn E.C. Interaction of pseudorabies virus with porcine peripheral blood lymphocytes. J Leukoc Biol 52 (1992) 441-448
25. Van Rooij E.M., Haagmans B.L., Glansbeek H.L., De Visser Y.E., De Bruin M.G., Boersma W.J., et al. A DNA vaccine coding for glycoprotein B of pseudorabies virus induces cell-mediated immunity in pigs and reduces virus excretion early after infection. Vet Immunol Immunopathol 74 (2000) 121-136
26. Fachinger V., Schlapp T., Strube W., Schmeer N., and Saalmuller A. Poxvirus-induced immunostimulating effects on porcine leucocytes. J Virol 74 (2000) 7943-7951
27. Terzić S., Jemersić L., Lojkić M., Sver L., Valpotić I., Orsolić N., et al. Leukocyte subsets and specific antibodies in pigs vaccinated with a classical swine fever subunit (E2) vaccine and the attenuated ORF virus strain D1701. Acta Vet Hung 52 (2004) 151-161
28. Wong P., Lara-Tejero M., Ploss A., Leiner I., and Pamer E.G. Rapid development of T cell memory. J Immunol 172 (2004) 7239-7245
29. Buchan S., Gronevik E., Mathiesen I., King C.A., Stevenson F.K., and Rice J. Electropration as a prime/boost strategy for naked DNA vaccination against a tumor antigen. J Immunol 174 (2005) 6292-6298
30. Radcliffe J.N., Roddick J.S., Stevenson F.K., and Thirdborough S.M. Prolonged antigen expression following DNA vaccination impairs effector CD8+ T cell function and memory development. J Immunol 179 (2007) 8313-8321
31. Van Rooij E.M., Glansbeek H.L., Hilgers L.A., te Lintelo E.G., de Visser Y.E., Boersma W.J., et al. Protective antiviral immune responses to pseudorabies virus induced by DNA vaccination using dimethyldioctadecylammonium bromide as an adjuvant. J Virol 76 (2002) 10540-10545
32. Martinon F, Kaldma K, Sikut R, Culina S, Romain G, Tuomela M, et al. Persistent immune responses induced by a HIV DNA vaccine in association with electroporation in the skin of nonhuman primates. Hum Gene Ther; 2009 July 23 [Epub ahead of print].
33. Low L, Mander A, McCann K, Dearnaley D, Tjelle T, Mathiesen I, et al. DNA vaccination with elecroporation induces increased antibody responses in patienst with prostate cancer. Hum Gene Ther; 2009 July 20 [Epub ahead of print].
34. Van Rooij E.M., Moonen-Leusen H.W., de Visser Y.E., Middel W.G., Boersma W.J., and Bianchi A.T. A DNA vaccine coding for gB and gD of pseudorabies virus (suid herpes type 1) primes the immune system in the presence of maternal immunity more efficiently than conventional vaccines. Vaccine 24 (2006) 1264-1273